4//SEC Filing
JDRF T1D Fund LLC 4
Accession 0000899243-20-019886
CIK 0001807901other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 7:45 PM ET
Size
11.5 KB
Accession
0000899243-20-019886
Insider Transaction Report
Form 4
JDRF T1D Fund LLC
10% Owner
Transactions
- Conversion
Common Stock
2020-07-21+204,313→ 204,313 total - Conversion
Common Stock
2020-07-21+222,020→ 426,333 total - Conversion
Series A Prime Preferred Stock
2020-07-21−948,225→ 0 total→ Common Stock (204,313 underlying) - Conversion
Series B Preferred Stock
2020-07-21−1,132,170→ 0 total→ Common Stock (222,020 underlying)
Footnotes (2)
- [F1]The Series A Prime Preferred Stock converted into Common Stock on a 4.6410-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Prime Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date
- [F2]The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Documents
Issuer
Pandion Therapeutics, Inc.
CIK 0001807901
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001817634
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 7:45 PM ET
- Size
- 11.5 KB